The vaccine, developed with the University of Oxford, has been described by the World Health Organization as probably the world’s leading candidate and the most advanced in terms of development. The suspension dims prospects for an early rollout amid reports that the United States was aiming for a fast-track approval before the November presidential election. “This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials,” the company said in an emailed statement. …read more
Source:: Yahoo Finance
